Clinical trial
Optimizing the Use of Ketamine to Reduce Chronic Postsurgical Pain
NCT05037123 is registered in ClinicalTrials.gov with NYU Langone Health as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Optimizing the Use of Ketamine to Reduce Chronic Postsurgical Pain
- Lead sponsor
- NYU Langone Health
- Phase
- Phase 3
- Overall status
- Active, not recruiting
- Start date
- January 4, 2022
- Completion date
- August 31, 2026
- Enrollment
- 765 (actual)
- Sites
- 14
Conditions
As the registry lists them; a condition with its own page is linked.
chronic postsurgical pain